Coronavirus Vaccine Side Effects: Some Suffer Bell s Palsy After Inoculation, FDA Reveals
KEY POINTS
Some COVID-19 vaccine participants suffered from Bell s palsy after receiving a shot
The FDA said there are not enough cases to determine whether the vaccine causes the condition
Symptoms of Bell s palsy typically lasts a few weeks
The U.S. Food and Drug Administration on Tuesday recommended the monitoring of people who receive the coronavirus vaccine after a handful of trial participants developed Bell’s palsy following inoculation.
In a 54-page staff report, the FDA cited four cases of Bell’s palsy among participants of Moderna’s COVID-19 vaccine trial, in which three invididuals were given the vaccine instead of a placebo.
Published: Dec 16, 2020 By Joseph Constance
A healthy immune system defends the body against disease and other conditions. However, if the immune system malfunctions, it can attack healthy cells, tissues and organs. Autoimmune disease impacts different parts of the body, weakening functionality. It may be life-threatening.
Researchers are aware of more than
80 diseases that occur when the immune system attacks the body’s own organs, tissues and cells. The more common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease.
Autoimmune diseases affect more than
24 million people in the U.S. On top of this, another 8 million carry auto-antibodies, blood molecules that indicate a person’s chance of developing an autoimmune disease. The cause of many of the diseases is unknown.
Americans are increasingly concerned about vaccine safety after four people in Pfizer-BioNTech trials and three people in the Moderna trials developed Bell’s palsy, a condition that causes temporary weakness or paralysis of the facial muscles.
While it may sound scary, experts say Bell’s palsy is more common and less severe than people think.
Bell’s palsy, also known as peripheral facial nerve palsy, can occur at any age, according to the Mayo Clinic. The exact causes are unknown, but it’s believed to be the result of swelling and inflammation of the nerve that controls the muscles on one side of the face, or a reaction after a viral infection.
Search jobs 16-Dec-2020 First patients dosed in Phase III trials evaluating Fasenra in hypereosinophilic syndrome, eosinophilic esophagitis and eosinophilic granulomatosis with polyangiitis
New clinical trial also announced for Fasenra
in eosinophilic gastritis/eosinophilic gastroenteritis
The first patients have been dosed in
Fasenra (benralizumab) Phase III trials in three rare eosinophilic diseases: hypereosinophilic syndrome (HES), eosinophilic esophagitis (EoE) and eosinophilic granulomatosis with polyangiitis (EGPA)
AstraZeneca will also initiate a Phase III trial to investigate the potential of
Fasenra in an additional rare eosinophilic disease: eosinophilic gastritis/eosinophilic gastroenteritis (EG/EGE). This trial extends the
Fasenra clinical programme to nine diseases where eosinophils play an important role, in addition to severe asthma.
Few Cases of Facial Paralysis Seen After COVID Vaccine medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.